According to Fortune Business Insights, the global Unna boot market size was valued at USD 271.8 million in 2025 and is projected to grow from USD 282.9 million in 2026 to USD 408.8 million by 2034, registering a CAGR of 4.7% during the forecast period. North America dominated the market with a 37.86% share in 2025, driven by a high prevalence of chronic wounds and advanced healthcare infrastructure.

An Unna boot is a medicated compression bandage made primarily of gauze infused with zinc oxide paste, used to treat:

• Venous leg ulcers
• Edema and swelling
• Stasis dermatitis
• Chronic lower-leg wounds

It provides compression therapy, wound protection, and healing support, making it a widely used solution in hospitals, clinics, and outpatient care.

Key players include 3M, Smith & Nephew, Essity, Medline Industries, Mölnlycke Health Care, and Integra LifeSciences.

MARKET OVERVIEW

Unna boots are considered a standard, cost-effective wound care solution, particularly for venous leg ulcers. Their continued use is driven by:

• Simplicity of application
• Proven clinical effectiveness
• Low cost compared to advanced therapies

They are especially relevant in long-term wound management, where affordability and accessibility are critical.

MARKET TRENDS

Preference for Simple and Affordable Wound Care

Healthcare providers increasingly prefer:

• Easy-to-use treatments
• Cost-efficient solutions
• Widely available products